These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India. Kumar A; Ray P; Kanwar M; Sethi S; Narang A J Hosp Infect; 2006 Feb; 62(2):248-50. PubMed ID: 16289456 [No Abstract] [Full Text] [Related]
35. Bates AS; Natarajan M; Reddy RV BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567079 [TBL] [Abstract][Full Text] [Related]
36. A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports. Asano K; Tada S; Matsumoto T; Miyase S; Kamio T; Sakurai K; Iida M J Hepatol; 2005 Aug; 43(2):362-5. PubMed ID: 15978693 [TBL] [Abstract][Full Text] [Related]
37. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis. De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244 [TBL] [Abstract][Full Text] [Related]
39. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. Parkins MD; Elborn JS J Antimicrob Chemother; 2010 Sep; 65(9):1853-61. PubMed ID: 20605846 [TBL] [Abstract][Full Text] [Related]
40. Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease. Stobbelaar K; Van Hoorenbeeck K; Lequesne M; De Dooy J; Ho E; Vlieghe E; Ieven M; Verhulst S Am J Case Rep; 2016 Aug; 17():562-6. PubMed ID: 27498677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]